Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
Ziad Hijazi, Alexander P. Benz, Johan Lindbäck, et al.
European Heart Journal (2022) Vol. 44, Iss. 3, pp. 208-218
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Atrial Cardiomyopathy Revisited - Evolution of a Concept. A Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Association (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
EP Europace (2024) Vol. 26, Iss. 9
Open Access | Times Cited: 45
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Dominik Linz, Jason G. Andrade, Elena Arbelo, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 38
Atrial fibrillation burden: a new outcome predictor and therapeutic target
Nina Becher, Andreas Metzner, Tobias Toennis, et al.
European Heart Journal (2024) Vol. 45, Iss. 31, pp. 2824-2838
Open Access | Times Cited: 30
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
Nina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
European Heart Journal (2023) Vol. 45, Iss. 10, pp. 837-849
Open Access | Times Cited: 36
Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study
Larissa Fabritz, Christoph Al-Taie, Katrin Borof, et al.
European Heart Journal (2024)
Open Access | Times Cited: 10
Disturbed atrial metabolism, shear stress, and cardiac load AF after ablation: AXAFA biomolecule study
Winnie Chua, Alya Khashaba, Hansel Canagarajah, et al.
EP Europace (2024) Vol. 26, Iss. 2
Open Access | Times Cited: 9
Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 209-209
Open Access | Times Cited: 9
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Lars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 11, pp. 1173-1185
Closed Access | Times Cited: 1
Insights into bone morphogenetic proteins in cardiovascular diseases
Di Ye, Yinghui Liu, Heng Pan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac Remodeling
Majd El‐Harasis, Joseph A. Quintana, Jose Roberto Martinez‐Parachini, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 7
Circulating BMP10 Levels Associate With Late Postoperative Atrial Fibrillation and Left Atrial Endomysial Fibrosis
Joris Winters, Michal Kawczynski, Martijn Gilbers, et al.
JACC. Clinical electrophysiology (2024) Vol. 10, Iss. 7, pp. 1326-1340
Open Access | Times Cited: 6
Insulin‐like growth factor binding protein‐7 concentrations in chronic heart failure: Results from the EMPEROR programme
João Pedro Ferreira, Milton Packer, Naveed Sattar, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 4, pp. 806-816
Closed Access | Times Cited: 5
Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study
Larissa Fabritz, Winnie Chua, Victor Roth Cardoso, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 8, pp. 855-868
Open Access | Times Cited: 5
Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches
Ulrich Schotten, Andreas Goette, Sander Verheule
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 5
Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation
Elisa Hennings, Stefanie Aeschbacher, Michael Coslovsky, et al.
EP Europace (2023) Vol. 25, Iss. 6
Open Access | Times Cited: 11
An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions
Winnie Chua, Victor Roth Cardoso, Eduard Guasch, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Association of Atrial Fibrillation Burden and Clinical Profile with Blood Biomarkers: Results from the ISOLATION Ablation Cohort
Zarina Habibi, D V M Verhaert, Konstanze Betz, et al.
Heart Rhythm O2 (2025)
Open Access
Atrial Cardiomyopathy in Atrial Fibrillation: A Multimodal Diagnostic Framework
Paschalis Karakasis, Panayotis K. Vlachakis, Panagiotis Theofilis, et al.
Diagnostics (2025) Vol. 15, Iss. 10, pp. 1207-1207
Open Access
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
Konstantinos I. Gkarmiris, Johan Lindbäck, John H. Alexander, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 2
Bone morphogenetic protein 10 and atrial fibrillation
Liang Liu, Yi Liang, Qigang Lan, et al.
IJC Heart & Vasculature (2024) Vol. 51, pp. 101376-101376
Open Access | Times Cited: 1
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation
Teodor Serban, Elisa Hennings, Ivo Strebel, et al.
Heart Rhythm (2024) Vol. 21, Iss. 9, pp. 1581-1588
Open Access | Times Cited: 1
Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure
Daan Ceelen, Valentina Bračun, Bart J van Essen, et al.
Heart (2024), pp. heartjnl-324486
Closed Access | Times Cited: 1
Addressing the pandemic of atrial fibrillation: optimization of catheter ablation and new therapeutic targets
Filippo Crea
European Heart Journal (2023) Vol. 44, Iss. 27, pp. 2413-2416
Open Access | Times Cited: 3
Management of atrial fibrillation: role of population screening, biomarkers, and polygenic risk scores
Filippo Crea
European Heart Journal (2023) Vol. 44, Iss. 3, pp. 167-170
Open Access | Times Cited: 1
Focus issue on vascular biology and medicine spanning from management of stroke to new therapeutic targets in aortic dissection and pulmonary hypertension
Filippo Crea
European Heart Journal (2023) Vol. 44, Iss. 14, pp. 1193-1196
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top